These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2327408)

  • 1. Porphyria cutanea tarda after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Guyotat D; Nicolas JF; Augey F; Fiere D; Thivolet J
    Am J Hematol; 1990 May; 34(1):69-70. PubMed ID: 2327408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appearance of an inherited porphyria cutanea tarda in a child after allogeneic bone marrow transplantation for chronic myelogenous leukaemia.
    Dopfer R; Doss M; Ehninger G; Ostendorf P; Niethammer D
    Bone Marrow Transplant; 1986 May; 1(1):95-9. PubMed ID: 3332125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Porphyria cutanea tarda in a patient undergoing bone marrow transplant. Addition of chronic cytomegalovirus hepatitis and multiple hepatic aggressions].
    Augey F; Nicolas JF; Guyotat D; Thivolet J
    Ann Dermatol Venereol; 1990; 117(5):363-6. PubMed ID: 2169223
    [No Abstract]   [Full Text] [Related]  

  • 5. Orthotopic liver transplantation for hepatic GVHD following allogeneic BMT for chronic myeloid leukaemia.
    Marks DI; Dousset B; Robson A; Imvrios G; Buckels JA; Elias E; Neuberger JM; Foster C; Batchelor R; Goldman JM
    Bone Marrow Transplant; 1992 Nov; 10(5):463-6. PubMed ID: 1464011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune pancytopenia following allogeneic bone marrow transplantation.
    Klumpp TR; Caligiuri MA; Rabinowe SN; Soiffer RJ; Murray C; Ritz J
    Bone Marrow Transplant; 1990 Dec; 6(6):445-7. PubMed ID: 1965793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin and stomach graft versus host disease after syngeneic BMT in CML: a case report.
    Pelosini M; Galimberti S; Benedetti E; Caracciolo F; Fazzi R; Petrini M; Papineschi F
    Leuk Res; 2007 Nov; 31(11):1603-4. PubMed ID: 17328949
    [No Abstract]   [Full Text] [Related]  

  • 9. Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.
    Bär BM; Schattenberg A; Mensink EJ; Geurts Van Kessel A; Smetsers TF; Knops GH; Linders EH; De Witte T
    J Clin Oncol; 1993 Mar; 11(3):513-9. PubMed ID: 8445426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
    Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD
    Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous pemphigoid associated with acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Delbaldo C; Rieckhoff-Cantoni L; Helg C; Saurat JH
    Bone Marrow Transplant; 1992 Oct; 10(4):377-9. PubMed ID: 1422495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
    Min CK; Kim DW; Lee JW; Min WS; Kim CC
    Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
    Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
    Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barre syndrome--pathological connection with GvHD after allogeneic bone marrow transplantation.
    Nasilowska-Adamska B; Lysiak Z; Halaburda K; Szczepinski A; Ejduk A; Marianska B
    Ann Transplant; 2006; 11(3):10-1. PubMed ID: 17494293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
    N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation.
    Santini V; Zoccolante A; Bosi A; Guidi S; Saccardi R; Vannucchi AM; Martinazzo G; Bernabei PA; Ferrini PR
    Haematologica; 1996; 81(3):201-7. PubMed ID: 8767524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    van Rhee F; Szydlo RM; Hermans J; Devergie A; Frassoni F; Arcese W; de Witte T; Kolb HJ; Niederwiser D; Jacobsen N; Gahrton G; Bandini G; Carreras E; Bacigalupo A; Michallet M; Ruutu T; Reiffers J; Goldman JM; Apperley J; Gratwohl A
    Bone Marrow Transplant; 1997 Oct; 20(7):553-60. PubMed ID: 9337056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Khoury H; Adkins D; Zehnbauer B; Goodnough L; Brown R; Safdar S; DiPersio JF
    Bone Marrow Transplant; 1998 Jul; 22(1):107-9. PubMed ID: 9678805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.